» Articles » PMID: 34903195

Wrist Circumference As a Novel Predictor of Transition from Metabolically Healthy to Unhealthy Phenotype in Overweight/obese Adults: a Gender-stratified 15.5-year Follow-up

Overview
Publisher Biomed Central
Specialty Public Health
Date 2021 Dec 14
PMID 34903195
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Individuals with transition from metabolically healthy overweight/obese (MHO) to metabolically unhealthy overweight/obese (MUO) phenotype are significantly predisposed to greater risks of cardiovascular events compared to those with a persistent MHO phenotype. The aim of this study was to evaluate the predictive performance of wrist circumference for this transition in adults over a 15.5-year follow-up.

Methods: We included 309 males and 821 females with the age of ≥18 years old, body mass index ≥25 kg/m, and metabolically healthy status according to the criteria of the Joint Interim Statement. The incidence of MUO phenotype was evaluated for each gender, across tertiles wrist circumference, using Cox-proportional hazard models.

Results: The overall rate of transition from MHO to MUO phenotype was 87.1% in males and 77.5% in females. The hazard ratios (HRs) with 95% CI across second and third tertiles of wrist circumference were 0.89 (0.64-1.24) and 1.31 (0.99-1.73) in men (P for trend =0.027); and 1.34 (1.09-1.66) and 1.61 (1.30-2.00) in women (P for trend <0.001), respectively. After multivariable adjustment, HRs across second and third tertiles of wrist circumference were 0.92 (0.64-1.32) and 1.18 (0.83-1.67) in males (p for trend =0.352), and 1.32 (1.05-1.65) and 1.34 (1.06-1.96) in females (p for trend =0.025), respectively.

Conclusions: Wrist circumference significantly predicts the transition from MHO to MUO phenotype in adults of both genders. However, it is an independent predictor of the transition only in females. Future studies are warranted to clarify the role of wrist circumference mechanisms on metabolic risk deterioration.

Citing Articles

Wrist Circumference Cutoff Points for Determining Excess Weight Levels and Predicting Cardiometabolic Risk in Adults.

Pereira L, de Souza M, Aidar F, Getirana-Mota M, Dos Santos-Junior A, Filho M Int J Environ Res Public Health. 2024; 21(5).

PMID: 38791764 PMC: 11120788. DOI: 10.3390/ijerph21050549.


Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus.

Pankova O, Korzh O Heart Vessels. 2023; 39(2):144-159.

PMID: 37758851 DOI: 10.1007/s00380-023-02318-w.


The Pathological Links between Adiposity and the Carpal Tunnel Syndrome.

Otelea M, Nartea R, Popescu F, Covaleov A, Mitoiu B, Nica A Curr Issues Mol Biol. 2022; 44(6):2646-2663.

PMID: 35735622 PMC: 9221759. DOI: 10.3390/cimb44060181.

References
1.
Povel C, Boer J, Reiling E, Feskens E . Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011; 12(11):952-67. DOI: 10.1111/j.1467-789X.2011.00907.x. View

2.
Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F . Wrist circumference as a novel predictor of hypertension and cardiovascular disease: results of a decade follow up in a West Asian cohort. J Am Soc Hypertens. 2014; 8(11):800-7. DOI: 10.1016/j.jash.2014.08.010. View

3.
Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan A, Saadat N, Khalili D . Wrist circumference as a novel predictor of diabetes and prediabetes: results of cross-sectional and 8.8-year follow-up studies. J Clin Endocrinol Metab. 2013; 98(2):777-84. DOI: 10.1210/jc.2012-2416. View

4.
Lin H, Zhang L, Zheng R, Zheng Y . The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article. Medicine (Baltimore). 2018; 96(47):e8838. PMC: 5708991. DOI: 10.1097/MD.0000000000008838. View

5.
. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1659-1724. PMC: 5388856. DOI: 10.1016/S0140-6736(16)31679-8. View